LV10426B - STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them - Google Patents
STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- LV10426B LV10426B LVP-92-358A LV920358A LV10426B LV 10426 B LV10426 B LV 10426B LV 920358 A LV920358 A LV 920358A LV 10426 B LV10426 B LV 10426B
- Authority
- LV
- Latvia
- Prior art keywords
- oxoethyl
- carbonyl
- cyclohexane
- methylamino
- hydroxylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI913448A IT1252708B (it) | 1991-12-23 | 1991-12-23 | Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10426A LV10426A (lv) | 1995-02-20 |
| LV10426B true LV10426B (en) | 1995-08-20 |
Family
ID=11361409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-92-358A LV10426B (en) | 1991-12-23 | 1992-12-23 | STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0575572A1 (fr) |
| JP (1) | JPH06506002A (fr) |
| CN (1) | CN1079474A (fr) |
| AU (1) | AU657591B2 (fr) |
| BG (1) | BG98050A (fr) |
| BR (1) | BR9205652A (fr) |
| CA (1) | CA2104372A1 (fr) |
| CZ (1) | CZ379692A3 (fr) |
| EE (1) | EE9400006A (fr) |
| FI (1) | FI933685A0 (fr) |
| HR (1) | HRP921454A2 (fr) |
| HU (1) | HUT69287A (fr) |
| IT (1) | IT1252708B (fr) |
| LV (1) | LV10426B (fr) |
| MA (1) | MA22749A1 (fr) |
| MX (1) | MX9207543A (fr) |
| NZ (1) | NZ245547A (fr) |
| PL (1) | PL169086B1 (fr) |
| PT (1) | PT101156A (fr) |
| RU (1) | RU2079489C1 (fr) |
| SI (1) | SI9200409A (fr) |
| SK (1) | SK379692A3 (fr) |
| TN (1) | TNSN92117A1 (fr) |
| WO (1) | WO1993013056A1 (fr) |
| YU (1) | YU110892A (fr) |
| ZA (1) | ZA9210004B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264860B1 (it) * | 1993-06-21 | 1996-10-17 | Guidotti & C Spa Labor | Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici |
| US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| FR2817241B1 (fr) | 2000-11-30 | 2003-03-07 | Cebal | Tube aluminium avec embout secable |
| CN101516191A (zh) * | 2006-09-28 | 2009-08-26 | 默克公司 | Saha的胺碱盐和其多晶型物 |
| AU2021263319B2 (en) * | 2020-04-27 | 2022-12-01 | Carter-Hoffmann, Llc | Door movement system for cabinet |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1224627B (it) * | 1988-04-12 | 1990-10-04 | Guidotti & C Spa Labor | Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono. |
-
1991
- 1991-12-23 IT ITMI913448A patent/IT1252708B/it active IP Right Grant
-
1992
- 1992-12-12 WO PCT/EP1992/002903 patent/WO1993013056A1/fr not_active Ceased
- 1992-12-12 CA CA002104372A patent/CA2104372A1/fr not_active Abandoned
- 1992-12-12 HU HU9302389A patent/HUT69287A/hu unknown
- 1992-12-12 BR BR9205652A patent/BR9205652A/pt not_active Application Discontinuation
- 1992-12-12 JP JP5511398A patent/JPH06506002A/ja active Pending
- 1992-12-12 EP EP92924726A patent/EP0575572A1/fr not_active Withdrawn
- 1992-12-12 AU AU30871/92A patent/AU657591B2/en not_active Ceased
- 1992-12-12 RU RU9293052414A patent/RU2079489C1/ru active
- 1992-12-12 FI FI933685A patent/FI933685A0/fi not_active Application Discontinuation
- 1992-12-21 CZ CS923796A patent/CZ379692A3/cs unknown
- 1992-12-21 SK SK3796-92A patent/SK379692A3/sk unknown
- 1992-12-21 NZ NZ245547A patent/NZ245547A/en unknown
- 1992-12-22 SI SI9200409A patent/SI9200409A/sl unknown
- 1992-12-22 MA MA23040A patent/MA22749A1/fr unknown
- 1992-12-22 HR HR921454A patent/HRP921454A2/hr not_active Application Discontinuation
- 1992-12-23 CN CN92113839A patent/CN1079474A/zh active Pending
- 1992-12-23 TN TNTNSN92117A patent/TNSN92117A1/fr unknown
- 1992-12-23 MX MX9207543A patent/MX9207543A/es unknown
- 1992-12-23 ZA ZA9210004A patent/ZA9210004B/xx unknown
- 1992-12-23 PL PL92297118A patent/PL169086B1/pl unknown
- 1992-12-23 YU YU110892A patent/YU110892A/sh unknown
- 1992-12-23 LV LVP-92-358A patent/LV10426B/lv unknown
- 1992-12-23 PT PT101156A patent/PT101156A/pt not_active Application Discontinuation
-
1993
- 1993-08-18 BG BG98050A patent/BG98050A/bg unknown
-
1994
- 1994-05-23 EE EE9400006A patent/EE9400006A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL169086B1 (pl) | 1996-05-31 |
| MX9207543A (es) | 1993-08-01 |
| PL297118A1 (en) | 1993-09-06 |
| HU9302389D0 (en) | 1993-11-29 |
| YU110892A (sh) | 1996-01-08 |
| FI933685A7 (fi) | 1993-08-20 |
| FI933685L (fi) | 1993-08-20 |
| CZ379692A3 (en) | 1993-09-15 |
| ITMI913448A1 (it) | 1993-06-23 |
| LV10426A (lv) | 1995-02-20 |
| CA2104372A1 (fr) | 1993-06-24 |
| NZ245547A (en) | 1995-12-21 |
| TNSN92117A1 (fr) | 1993-06-08 |
| WO1993013056A1 (fr) | 1993-07-08 |
| EE9400006A (et) | 1995-12-15 |
| ZA9210004B (en) | 1993-12-13 |
| HRP921454A2 (en) | 1995-02-28 |
| BG98050A (bg) | 1994-04-29 |
| EP0575572A1 (fr) | 1993-12-29 |
| MA22749A1 (fr) | 1993-07-01 |
| AU657591B2 (en) | 1995-03-16 |
| AU3087192A (en) | 1993-07-28 |
| HUT69287A (en) | 1995-09-28 |
| IT1252708B (it) | 1995-06-26 |
| FI933685A0 (fi) | 1993-08-20 |
| SI9200409A (en) | 1993-09-30 |
| PT101156A (pt) | 1994-06-30 |
| JPH06506002A (ja) | 1994-07-07 |
| RU2079489C1 (ru) | 1997-05-20 |
| SK379692A3 (en) | 1995-04-12 |
| CN1079474A (zh) | 1993-12-15 |
| ITMI913448A0 (it) | 1991-12-23 |
| BR9205652A (pt) | 1994-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890000007B1 (ko) | 시스, 엔도-2-아자비사이클로-[3.3.0]-옥탄-3-카복실산 유도체의 제조방법 | |
| US4714708A (en) | Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic acid, and their use for treating hypertension | |
| IE60128B1 (en) | Hydroxylamine derivatives,their preparation and use as medicaments | |
| JPS6388166A (ja) | ジアミン類の選択的アミジン化 | |
| JPS58177968A (ja) | アザスピロ−カルボン酸誘導体 | |
| JPH0547538B2 (fr) | ||
| EP0105102A1 (fr) | Dérivés d'acides 2-aza-bicyclo(2,2,2)-octane-3-carboxyliques, leur procédé de préparation, les médicaments les contenant et leur application, ainsi que l'acide 2-aza-bicyclo(2,2,2)-octane-3-carboxylique comme intermédiaire et le procédé pour sa préparation | |
| IE56544B1 (en) | New spirocyclic aminoacid derivatives,processes for their preparation,agents containing them and their use and new spirocyclic aminoacids as intermediates and processes for their preparation | |
| NO851495L (no) | Syntese av cyklopropanaminosyrer og -peptider | |
| LV10426B (en) | STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them | |
| HK1000209A1 (en) | Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative | |
| HK1000209B (en) | Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative | |
| JPH0531544B2 (fr) | ||
| IE56654B1 (en) | A process for the resolution of racemates of optically active bicyclic imino-alpha-carboxylic esters,and the use of the compounds thus obtainable for the synthesis of carboxyalkyldipeptides | |
| US4920144A (en) | Derivatives of bicyclic amino acids, agents containing them and their use as hypotensives | |
| US4370494A (en) | Converting enzyme inhibitors | |
| DD206553A5 (de) | Verfahren zur herstellung von tripeptiden | |
| US4113877A (en) | Substituted 2-aminomethylphenyl sulfamates | |
| US5175306A (en) | Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters | |
| US5948939A (en) | Selective amidination of diamines | |
| JPH021446A (ja) | N‐ヒドロキシ‐α‐アミノ酸およびその誘導体の製造法、ならびにこうして得られた化合物 | |
| IE53315B1 (en) | Substituted dipeptides,processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase | |
| IKEDA et al. | Total syntheses of bellenamine and its isomers | |
| NZ223500A (en) | Benzazepin-2-one derivatives and pharmaceutical compositions | |
| US4073807A (en) | Propionamide antitumor agents |